Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction -- Data Supplement - Supporting Figures -- Proceedings of the National Academy of Sciences

Supporting information for Schmollinger et al. (2003) Proc. Natl. Acad. Sci. USA, 10.1073/pnas.053031100

JPEG Image

Fig. 5.
ML-IAP-specific T cell responses. The JS34 peptide elicited IFN-γ production from CD8⁺T cells in the calf metastasis. Spots were (no. of replicate wells) as follows: Tax (2, 0); JS34 (36, 20); and JS90 (1, 2).